IBDEI1XF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32257,1,4,0)
 ;;=4^F45.41
 ;;^UTILITY(U,$J,358.3,32257,2)
 ;;=^5003590
 ;;^UTILITY(U,$J,358.3,32258,0)
 ;;=F45.42^^141^1513^6
 ;;^UTILITY(U,$J,358.3,32258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32258,1,3,0)
 ;;=3^Pain Disorder w/ Related Psychological Factors
 ;;^UTILITY(U,$J,358.3,32258,1,4,0)
 ;;=4^F45.42
 ;;^UTILITY(U,$J,358.3,32258,2)
 ;;=^5003591
 ;;^UTILITY(U,$J,358.3,32259,0)
 ;;=F45.0^^141^1513^7
 ;;^UTILITY(U,$J,358.3,32259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32259,1,3,0)
 ;;=3^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,32259,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,32259,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,32260,0)
 ;;=F45.9^^141^1513^8
 ;;^UTILITY(U,$J,358.3,32260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32260,1,3,0)
 ;;=3^Somatoform Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,32260,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,32260,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,32261,0)
 ;;=F45.1^^141^1513^10
 ;;^UTILITY(U,$J,358.3,32261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32261,1,3,0)
 ;;=3^Undifferntiated Somatoform Disorder
 ;;^UTILITY(U,$J,358.3,32261,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,32261,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,32262,0)
 ;;=99605^^142^1514^1^^^^1
 ;;^UTILITY(U,$J,358.3,32262,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32262,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,32262,1,3,0)
 ;;=3^99605
 ;;^UTILITY(U,$J,358.3,32263,0)
 ;;=99607^^142^1514^2^^^^1
 ;;^UTILITY(U,$J,358.3,32263,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32263,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,32263,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,32264,0)
 ;;=99606^^142^1515^1^^^^1
 ;;^UTILITY(U,$J,358.3,32264,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32264,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,32264,1,3,0)
 ;;=3^99606
 ;;^UTILITY(U,$J,358.3,32265,0)
 ;;=99607^^142^1515^2^^^^1
 ;;^UTILITY(U,$J,358.3,32265,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32265,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,32265,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,32266,0)
 ;;=98960^^142^1516^1^^^^1
 ;;^UTILITY(U,$J,358.3,32266,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32266,1,2,0)
 ;;=2^INDIVIDUAL PATIENT, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,32266,1,3,0)
 ;;=3^98960
 ;;^UTILITY(U,$J,358.3,32267,0)
 ;;=98961^^142^1516^2^^^^1
 ;;^UTILITY(U,$J,358.3,32267,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32267,1,2,0)
 ;;=2^2-4 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,32267,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,32268,0)
 ;;=98962^^142^1516^3^^^^1
 ;;^UTILITY(U,$J,358.3,32268,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32268,1,2,0)
 ;;=2^5-8 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,32268,1,3,0)
 ;;=3^98962
 ;;^UTILITY(U,$J,358.3,32269,0)
 ;;=T74.11XA^^143^1517^8
 ;;^UTILITY(U,$J,358.3,32269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32269,1,3,0)
 ;;=3^Spouse/Partner or Nonspouse/Nonpartner Violence,Physical,Confirmed,Initial Encounter
 ;;^UTILITY(U,$J,358.3,32269,1,4,0)
 ;;=4^T74.11XA
 ;;^UTILITY(U,$J,358.3,32269,2)
 ;;=^5054146
 ;;^UTILITY(U,$J,358.3,32270,0)
 ;;=T74.11XD^^143^1517^9
 ;;^UTILITY(U,$J,358.3,32270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32270,1,3,0)
 ;;=3^Spouse/Partner or Nonspouse/Nonpartner Violence,Physical,Confirmed,Subsequent Encounter
 ;;^UTILITY(U,$J,358.3,32270,1,4,0)
 ;;=4^T74.11XD
 ;;^UTILITY(U,$J,358.3,32270,2)
 ;;=^5054147
 ;;^UTILITY(U,$J,358.3,32271,0)
 ;;=T76.11XA^^143^1517^10
 ;;^UTILITY(U,$J,358.3,32271,1,0)
 ;;=^358.31IA^4^2
